ES2616095T3 - Derivados de 2-(1H-indolilsulfanil)-aril-amina - Google Patents
Derivados de 2-(1H-indolilsulfanil)-aril-amina Download PDFInfo
- Publication number
- ES2616095T3 ES2616095T3 ES06808965.5T ES06808965T ES2616095T3 ES 2616095 T3 ES2616095 T3 ES 2616095T3 ES 06808965 T ES06808965 T ES 06808965T ES 2616095 T3 ES2616095 T3 ES 2616095T3
- Authority
- ES
- Spain
- Prior art keywords
- methyl
- phenyl
- ylsulfanyl
- amine
- indol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69200905P | 2005-06-17 | 2005-06-17 | |
| US692009P | 2005-06-17 | ||
| PCT/IB2006/002785 WO2006134499A2 (en) | 2005-06-17 | 2006-06-14 | 2-(1h-indolylsulfanyl)-aryl amine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2616095T3 true ES2616095T3 (es) | 2017-06-09 |
Family
ID=37532681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES06808965.5T Expired - Lifetime ES2616095T3 (es) | 2005-06-17 | 2006-06-14 | Derivados de 2-(1H-indolilsulfanil)-aril-amina |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1893575B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5144507B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080027462A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101238101A (cg-RX-API-DMAC7.html) |
| AR (1) | AR054394A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006257288A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0611748A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2611566C (cg-RX-API-DMAC7.html) |
| EA (1) | EA200800070A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2616095T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL188064A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007014954A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20080265L (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006134499A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200710885B (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010540461A (ja) * | 2007-09-24 | 2010-12-24 | ハー・ルンドベック・アクチエゼルスカベット | セロトニン二重作用化合物に関する併用療法 |
| TW200938189A (en) * | 2008-03-13 | 2009-09-16 | Lundbeck & Co As H | [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| EP2606031B1 (en) | 2010-08-20 | 2017-09-27 | Amira Pharmaceuticals, Inc. | Autotaxin inhibitors and uses thereof |
| US9260416B2 (en) | 2011-05-27 | 2016-02-16 | Amira Pharmaceuticals, Inc. | Heterocyclic autotaxin inhibitors and uses thereof |
| US10179781B2 (en) * | 2013-03-15 | 2019-01-15 | Chromocell Corporation | Sodium channel modulators for the treatment of pain |
| EP3046909A4 (en) | 2013-09-17 | 2017-03-29 | Pharmakea, Inc. | Heterocyclic vinyl autotaxin inhibitor compounds |
| US9714240B2 (en) | 2013-09-17 | 2017-07-25 | Pharmakea, Inc. | Vinyl autotaxin inhibitor compounds |
| US9850203B2 (en) | 2013-09-26 | 2017-12-26 | Pharmakea, Inc. | Autotaxin inhibitor compounds |
| PE20160654A1 (es) | 2013-11-22 | 2016-07-15 | Pharmakea Inc | Compuestos de inhibidor de autotaxina |
| CN116059203A (zh) | 2015-05-27 | 2023-05-05 | 赛博治疗有限责任公司 | 自分泌运动因子抑制剂及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4117129A (en) * | 1976-10-22 | 1978-09-26 | Warner-Lambert Company | Indolobenzoxazepines as cns depressants |
| ATE195125T1 (de) * | 1995-11-06 | 2000-08-15 | Dsm Nv | Verfahren zur de-esterifikation |
| UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| TW200400177A (en) * | 2002-06-04 | 2004-01-01 | Wyeth Corp | 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| EP1701940B1 (en) * | 2003-12-23 | 2008-05-28 | H.Lundbeck A/S | 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| AR052308A1 (es) * | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
-
2006
- 2006-06-13 AR ARP060102491A patent/AR054394A1/es not_active Application Discontinuation
- 2006-06-14 KR KR1020077029334A patent/KR20080027462A/ko not_active Withdrawn
- 2006-06-14 ES ES06808965.5T patent/ES2616095T3/es not_active Expired - Lifetime
- 2006-06-14 CN CNA2006800218382A patent/CN101238101A/zh active Pending
- 2006-06-14 BR BRPI0611748A patent/BRPI0611748A2/pt not_active IP Right Cessation
- 2006-06-14 EP EP06808965.5A patent/EP1893575B1/en not_active Expired - Lifetime
- 2006-06-14 CA CA2611566A patent/CA2611566C/en not_active Expired - Fee Related
- 2006-06-14 JP JP2008516452A patent/JP5144507B2/ja not_active Expired - Fee Related
- 2006-06-14 EA EA200800070A patent/EA200800070A1/ru unknown
- 2006-06-14 AU AU2006257288A patent/AU2006257288A1/en not_active Abandoned
- 2006-06-14 MX MX2007014954A patent/MX2007014954A/es not_active Application Discontinuation
- 2006-06-14 ZA ZA200710885A patent/ZA200710885B/xx unknown
- 2006-06-14 WO PCT/IB2006/002785 patent/WO2006134499A2/en not_active Ceased
-
2007
- 2007-12-11 IL IL188064A patent/IL188064A0/en unknown
-
2008
- 2008-01-15 NO NO20080265A patent/NO20080265L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA200800070A1 (ru) | 2008-04-28 |
| AR054394A1 (es) | 2007-06-20 |
| BRPI0611748A2 (pt) | 2016-11-22 |
| KR20080027462A (ko) | 2008-03-27 |
| ZA200710885B (en) | 2009-03-25 |
| WO2006134499A3 (en) | 2007-04-12 |
| NO20080265L (no) | 2008-01-15 |
| JP5144507B2 (ja) | 2013-02-13 |
| WO2006134499A2 (en) | 2006-12-21 |
| MX2007014954A (es) | 2008-02-15 |
| CA2611566C (en) | 2011-08-16 |
| EP1893575B1 (en) | 2017-01-11 |
| CA2611566A1 (en) | 2006-12-21 |
| EP1893575A2 (en) | 2008-03-05 |
| JP2008546679A (ja) | 2008-12-25 |
| CN101238101A (zh) | 2008-08-06 |
| AU2006257288A1 (en) | 2006-12-21 |
| IL188064A0 (en) | 2008-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI92397C (fi) | Menetelmä valmistaa farmaseuttisesti käyttökelpoisia indolijohdoksia | |
| US7737171B2 (en) | Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS | |
| CA2611566C (en) | 2-(1h-indolylsulfanyl)-aryl amine derivatives | |
| ES2317266T3 (es) | Derivados de 2-(1h-indolilsulfanil)-arilamina para uso en el tratamiento de trastornos afectivos, dolor, hiperactividad con deficit de atencion e incontinencia urinaria por esfuerzo. | |
| US7629473B2 (en) | 2-(1H-indolylsulfanyl)-aryl amine derivatives | |
| US20090192213A1 (en) | Benzo[b]furane And Benzo[b]thiophene Derivatives | |
| ES2362237T3 (es) | Derivados de 2-(1h-indolilsulfanil)-bencilamina como isrs. | |
| HK1119674A (en) | Benzo[b]furane and benzo[b]thiophene derivatives | |
| KR20070017240A (ko) | Ssri로서 2-(1h-인돌릴술파닐)-벤질 아민 유도체 |